Tratamento percutâneo vs. cirúrgico da persistência do canal arterial em crianças e adolescentes

Costa, Rodrigo Nieckel da; Pereira, Fabrício Leite; Ribeiro, Marcelo Silva; Pedra, Simone Fontes; Succi, Fabiana Moreira Passos; Marques, Pedro Valentim; Jatene, Marcelo Biscegli; Fontes, Valmir F.; Pedra, Carlos Augusto Cardoso

doi:10.1590/s2179-83972012000300016

Cited by 4 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Rudimentary prostheses, cumbersome delivery systems and techniques, high rate of complications, and low rates of occlusion did not bring popularity to the new method. Novel and more accessible techniques, development of modern prostheses, high occlusion rates, low complications rates, and the user-friendly delivery systems with lower profile have defined percutaneous occlusion od ductus arteriosus as the treatment of choice in the pediatric population, 2 sharing this indication only with surgical treatment in low-birthweight neonates. 3 The indications for ductus arteriosus closure are significant left-right shunt, signs of overload in left cavities, which can progress to heart failure, and low weight gain and its many consequences.…”

Section: Introductionmentioning

confidence: 99%

Percutaneous occlusion of ductus arteriosus with Amplatzer™ Duct Occluder II AS

Bergman¹,

Agostinho²,

Christiani³

et al. 2021

J Transcat Intervent

View full text Add to dashboard Cite

Background Percutaneous occlusion of ductus arteriosus is well established as the method of choice to treat this structural heart defect. A new generation of Amplatzer™ Duct Occluder II Aditional Sizes prostheses, with lower profile and greater flexibility, in addition to smaller retention discs, was developed for percutaneous treatment of patent ductus arteriosus. This study intended to demonstrate the experience of one center with the use of this device, evaluating technical aspects, immediate occlusion rates, and complications. Methods A retrospective study of a cohort of patients with patent ductus arteriosus treated with Amplatzer™ Duct Occluder II Aditional Sizes. Between October 2018 and March 2021, 27 patients with patent ductus arteriosus, types A and E according to the Krichenko classification, were treated with Amplatzer™ Duct Occluder II Aditional Sizes. The prosthesis was implanted by the usual anterograde approach in 25 patients, and retrograde in two cases. The prosthesis chosen were 2mm larger than the core of the defect, and the length of the prosthesis was 2mm for shorter lesions and smaller infants, and between 4 and 6mm for longer lesions. Results Out of 27 patients, 52% were female, with a mean age and weight of 44.2 months (1 to 135 months) and 15.8kg (2,0 to 29kg), respectively. In the sample, 11 patients presented type A patent ductus arteriosus, and 16 type E, with a mean ratio of 1.9:1 between the prosthesis waist and the central diameter. In all patients, the device was successfully implanted, and only one patient remained with residual shunt, presenting embolization of the prosthesis. This patient had the ductus arteriosus closed by another prosthesis. Conclusion Amplatzer™ Duct Occluder II Aditional Sizes demonstrated safety, versatility, and efficiency in cases of appropriate anatomy. The experience demonstrated here is from a single center, with the Amplatzer™ Duct Occluder II Aditional Sizes. Its increased flexibility and softness demand greater operator expertise.

show abstract

Section: Introductionmentioning

confidence: 99%

Percutaneous occlusion of ductus arteriosus with Amplatzer™ Duct Occluder II AS

Bergman¹,

Agostinho²,

Christiani³

et al. 2021

J Transcat Intervent

View full text Add to dashboard Cite

show abstract

“…Especialmente em prematuros, esta anormalidade resulta em alterações hemodinâmicas graves com consequentes morbidades que afetam os sistemas renal, respiratório e gastrointestinal. Desse modo, o reconhecimento precoce desta patologia é de fundamental importância em virtude da implicação prognóstica pela própria deterioração clínica e da sua alta mortalidade, devendo-se implementar o tratamento o mais rápido possível para prevenir o aparecimento de complicações [4][5][6] .…”

Section: Introductionunclassified

Perfil Dos Recém-Nascidos Com Diagnóstico De Persistência Do Canal Arterial Em Um Hospital Terciário Do Oeste Paulista

Disconzi¹,

Moretti²

2018

COLLOQ VITAE

View full text Add to dashboard Cite

As deformidades cardíacas congênitas são definidas como uma anormalidade cardiocirculatória estrutural e funcional presente desde o nascimento. O canal arterial é uma estrutura vital para o feto na vida intraútero, e sua abertura persistente após o nascimento pode implicar em serias complicações. Assim, o presente trabalho teve como objetivo caracterizar o perfil dos recém-nascidos com diagnóstico ecocardiográfico de persistência do canal arterial (PCA). Trata-se de um estudo transversal, de cunho retrospectivo, com abordagem quantitativa e analise descritiva de neonatos atendidos em um hospital terciário do Oeste Paulista, realizado no período de janeiro de 2015 a dezembro de 2016. Alguns elementos que se relacionam à PCA como a idade materna (>18 anos), parto cesárea, baixo peso ao nascer, idade gestacional ao nascimento, Apgar no 5º minuto menor que 7, injúrias hipóxicas e associação com outras cardiopatias foram encontrados nessa casuística. Palavras-chave: persistência do canal arterial, perfil epidemiológico, neonatos.

show abstract